Vital Therapies (VTL) Reports In-Line Q1 EPS

Vital Therapies (NASDAQ: VTL) reported Q1 EPS of ($0.34), in-line with the analyst estimate of ($0.34).

For earnings history and earnings-related data on Vital Therapies (VTL) click here.

You May Also Be Interested In

• uCloudlink Group Inc. (UCL) Misses Q2 EPS by 1c ; Offers Guidance
• BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
• Freightos Limited (CRGO) Tops Q2 EPS by 3c ; Offers Guidance